Amgen Inc. v. Sanofi

GPTKB entity

Statements (63)
Predicate Object
gptkbp:instance_of gptkb:legal_case
gptkbp:appeals_to patent infringement
gptkbp:area patent law
gptkbp:case_analysis research and development
legal scholars
biotech innovation
legal commentary
legal forums
future litigation
patent law evolution
impact on stakeholders
gptkbp:case_number court records
litigation history
legal overview
2019-1140
gptkbp:case_outcome gptkb:healthcare_access
gptkb:majority_opinion
industry standards
market competition
investment strategies
legal certainty
market dynamics
regulatory environment
drug pricing
monetary damages
legal reviews
innovation landscape
biotech sector
affirmed lower court
biotech funding
patent clarity
gptkbp:case_significance intellectual property rights
gptkbp:clinical_trial gptkb:court_cases
gptkbp:consequences patent enforcement
gptkbp:court gptkb:United_States_Court_of_Appeals_for_the_Federal_Circuit
gptkbp:decided_by gptkb:2023
en banc
gptkbp:dissenting_opinion dissenting judges
gptkbp:duration 9 years
https://www.w3.org/2000/01/rdf-schema#label Amgen Inc. v. Sanofi
gptkbp:impact innovation in drug development
gptkbp:involves gptkb:Sanofi
gptkb:Amgen_Inc.
gptkbp:is_cited_in 2023 WL 1234567
gptkbp:jurisdiction gptkb:United_States
gptkbp:legal_issue written description
gptkbp:legal_outcome patent upheld
gptkbp:legal_principle litigation tactics
enablement
gptkbp:legal_representation law firms
gptkbp:legislation Patent Act
gptkbp:outcome biopharmaceutical patents
patent validity
gptkbp:party gptkb:court_cases
gptkbp:precedent biotechnology patents
future patent cases
gptkbp:publication_year gptkb:2014
gptkbp:related_cases gptkb:Amgen_Inc._v._Sandoz_Inc.
gptkbp:related_to biologics
gptkbp:significance impact on pharmaceutical industry
gptkbp:witnesses scientific evidence
gptkbp:bfsParent gptkb:United_States_Court_of_Appeals_for_the_Federal_Circuit
gptkbp:bfsLayer 5